Large-scale vaccination campaigns have prevented countless hospitalizations and deaths
due to COVID-19. However, the emergence of SARS-CoV-2 variants that escape from …

Background Emerging and future SARS-CoV-2 variants may jeopardize the effectiveness of
vaccination campaigns. Therefore, it is important to know how the different vaccines perform …

Emerging SARS-CoV-2 variants of concern (VOCs) pose a threat to human immunity induced
by natural infection and vaccination. We assessed the recognition of three VOCs (B.1.1.7, B…

Background Few robust longitudinal data on long-term coronavirus disease 2019 (COVID-19)
symptoms are available. We evaluated symptom onset, severity and recovery across the …

Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …

Background Symptoms of post-acute sequelae of COVID-19 (PASC) may improve following
SARS-CoV-2 vaccination. However few prospective data that also explore the underlying …

Large-scale vaccination campaigns have prevented countless SARS-CoV-2 infections,
hospitalizations and deaths. However, the emergence of variants that escape from immunity …

Background Currently, there is limited evidence about the long-term impact on physical, social
and emotional functioning, ie health-related quality of life (HRQL) after mild or moderate …

Background Severe fatigue can persist for months after coronavirus disease 2019 (COVID-19)
onset. This longitudinal study describes fatigue severity and its determinants up to 12 …

The urgent need for, but limited availability of, SARS-CoV-2 vaccines worldwide has led to
widespread consideration of dose-sparing strategies. Here, we evaluate the SARS-CoV-2-…